PHILADELPHIA CHROMOSOME POSITIVE CML
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE CML explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE CML trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may let CML patients pause treatment
Disease control OngoingThis phase 2 trial tests whether starting with a stronger drug (ponatinib) for 6 months, then switching to a standard drug (imatinib) for at least 30 months, can help adults with newly diagnosed chronic myeloid leukemia reach deep remission. The goal is to see if patients can the…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for kids with rare leukemia: bosutinib trial underway
Disease control OngoingThis study tests the drug bosutinib in 60 children with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Some children are newly diagnosed, while others have not responded to or cannot tolerate other treatments. The goal is to find the best dose and see if the…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 26, 2026 17:34 UTC